212 related articles for article (PubMed ID: 36372644)
1. Perspectives of physicians and medical assistants on the implementation of NAAT-based point-of-care testing for SARS-CoV-2 in primary care in Germany.
Wolf F; Matthes A; Markwart R; Bleidorn J
Z Evid Fortbild Qual Gesundhwes; 2022 Dec; 175():43-49. PubMed ID: 36372644
[TBL] [Abstract][Full Text] [Related]
2. Point-of-care laboratory testing in primary care: utilization, limitations and perspectives of general practitioners in Germany.
Matthes A; Wolf F; Schmiemann G; Gágyor I; Bleidorn J; Markwart R
BMC Prim Care; 2023 Apr; 24(1):96. PubMed ID: 37038122
[TBL] [Abstract][Full Text] [Related]
3. One swab, two tests: Validation of dual SARS-CoV-2 testing on the Abbott ID NOW™.
Burnes LE; Clark ST; Sheldrake E; Faheem A; Poon BP; Christie-Holmes N; Finlay L; Kandel C; Phan M; Frankland C; Lau T; Gubbay JB; Corbeil A; Katz K; Kozak RA
J Clin Virol; 2021 Aug; 141():104896. PubMed ID: 34174710
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic accuracy and feasibility of a rapid SARS-CoV-2 antigen test in general practice - a prospective multicenter validation and implementation study.
Rohde J; Himmel W; Hofinger C; Lâm TT; Schrader H; Wallstabe J; Kurzai O; Gágyor I
BMC Prim Care; 2022 Jun; 23(1):149. PubMed ID: 35690722
[TBL] [Abstract][Full Text] [Related]
6. Performances of the VitaPCR™ SARS-CoV-2 Assay during the second wave of the COVID-19 epidemic in France.
Fitoussi F; Dupont R; Tonen-Wolyec S; Bélec L
J Med Virol; 2021 Jul; 93(7):4351-4357. PubMed ID: 33738829
[TBL] [Abstract][Full Text] [Related]
7. Clinical and operational impact of rapid point-of-care SARS-CoV-2 detection in an emergency department.
Gerlier C; Pilmis B; Ganansia O; Le Monnier A; Nguyen Van JC
Am J Emerg Med; 2021 Dec; 50():713-718. PubMed ID: 34879491
[TBL] [Abstract][Full Text] [Related]
8. Beliefs and practices among primary care physicians during the first wave of the COVID-19 pandemic in Baden-Wuerttemberg (Germany): an observational study.
Roth C; Breckner A; Moellinger S; Schwill S; Peters-Klimm F; Szecsenyi J; Stengel S; Wensing M
BMC Fam Pract; 2021 May; 22(1):86. PubMed ID: 33952205
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity and Diagnostic Yield of the First SARS-CoV-2 Nucleic Acid Amplification Test Performed for Patients Presenting to the Hospital.
Hohl CM; Hau JP; Vaillancourt S; Grant J; Brooks SC; Morrison LJ; Perry JJ; Rosychuk RJ;
JAMA Netw Open; 2022 Oct; 5(10):e2236288. PubMed ID: 36223119
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of an antigen-based test for hospital point-of-care diagnosis of SARS-CoV-2 infection.
Bianco G; Boattini M; Barbui AM; Scozzari G; Riccardini F; Coggiola M; Lupia E; Cavallo R; Costa C
J Clin Virol; 2021 Jun; 139():104838. PubMed ID: 33946040
[TBL] [Abstract][Full Text] [Related]
11. Experiences made by family physicians managing patients with SARS-CoV-2 infection during spring 2020 - a cross-sectional analysis.
Strumann C; von Meißner WCG; Blickle PG; Held L; Steinhäuser J
Z Evid Fortbild Qual Gesundhwes; 2021 Oct; 165():35-42. PubMed ID: 34474994
[TBL] [Abstract][Full Text] [Related]
12. Use of Rapid Antigen Testing for SARS-CoV-2 in Remote Communities - Yukon-Kuskokwim Delta Region, Alaska, September 15, 2020-March 1, 2021.
Hodges E; Lefferts B; Bates E; Desnoyers C; Bruden D; Bruce M; McLaughlin J
MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(33):1120-1123. PubMed ID: 34411078
[TBL] [Abstract][Full Text] [Related]
13. Use, Safety Assessment, and Implementation of Two Point-of-Care Tests for COVID-19 Testing.
Hahn M; Olsen A; Stokes K; Fowler RC; Gu R; Semple-Lytch S; DeVito A; Kurpiel P; Hughes S; Rakeman JL
Am J Clin Pathol; 2021 Aug; 156(3):370-380. PubMed ID: 34302455
[TBL] [Abstract][Full Text] [Related]
14. Detection of SARS-CoV-2 Based on Nucleic Acid Amplification Tests (NAATs) and Its Integration into Nanomedicine and Microfluidic Devices as Point-of-Care Testing (POCT).
Dorta-Gorrín A; Navas-Méndez J; Gozalo-Margüello M; Miralles L; García-Hevia L
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373381
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness and use of reverse transcriptase polymerase chain reaction point of care testing in a large-scale COVID-19 surveillance system.
Mack CD; Wasserman EB; Hostler CJ; Solomon G; Anderson DJ; Walton P; Hawaldar K; Myers E; Best M; Eichner D; Mayer T; Sills A
Pharmacoepidemiol Drug Saf; 2022 May; 31(5):511-518. PubMed ID: 35225407
[TBL] [Abstract][Full Text] [Related]
16. "It Was Very Comforting to Find Out Right Away." - Patient Perspectives on Point-of-Care Molecular SARS-CoV-2 Testing in Primary Care.
Matthes A; Wolf F; Bleidorn J; Markwart R
Patient Prefer Adherence; 2022; 16():2031-2039. PubMed ID: 35975172
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of water gargle samples for SARS-CoV-2 detection using Abbott ID NOW COVID-19 assay.
Lévesque S; Beauchemin S; Vallée M; Longtin J; Jacob-Wagner M; Dumaresq J; Dulcey C; Labbé AC
J Med Virol; 2022 Sep; 94(9):4522-4527. PubMed ID: 35535382
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of the ID-NOW™ test for the rapid detection of SARS-CoV-2.
Kepka Z; Briksi A; Hubáček P; Zajac M; Dřevínek P
Epidemiol Mikrobiol Imunol; 2023; 72(1):3-8. PubMed ID: 37185021
[TBL] [Abstract][Full Text] [Related]
19. Strategies That Facilitate Extraction-Free SARS-CoV-2 Nucleic Acid Amplification Tests.
Delgado-Diaz DJ; Sakthivel D; Nguyen HHT; Farrokzhad K; Hopper W; Narh CA; Richards JS
Viruses; 2022 Jun; 14(6):. PubMed ID: 35746782
[TBL] [Abstract][Full Text] [Related]
20. Multi-center evaluation of cepheid xpert® xpress SARS-CoV-2 point-of-care test during the SARS-CoV-2 pandemic.
Wolters F; van de Bovenkamp J; van den Bosch B; van den Brink S; Broeders M; Chung NH; Favié B; Goderski G; Kuijpers J; Overdevest I; Rahamat-Langedoen J; Wijsman L; Melchers WJ; Meijer A
J Clin Virol; 2020 Jul; 128():104426. PubMed ID: 32417674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
